tradmap

OSCR Oscar Health, Inc.

$31.00 +2.11%

Data as of close

Financial · Hospital & Medical Service Plans

Oscar Health, Inc. (OSCR) is a financial company in the Hospital & Medical Service Plans industry, with a market capitalization of $9.6 billion. Shares last traded at $31.00, 13.9% below their 52-week high. Over the past year the stock is up 71.3%. OSCR trades at a price-to-earnings ratio of 17.37, below the Hospital & Medical Service Plans median of 24.01. Net profit margin is 4.7%, above the peer median of 1.1%. Revenue grew 39.0% year over year.

Market Cap
$9.6B
Shares Out
308.6M
EPS (TTM)
$1.45
P/E (TTM)*
17.37
P/S Ratio
0.82
P/B Ratio
4.66
Dividend / Share
—
Dividend Yield
—
52-Week High
$36.00
52-Week Low
$10.70
Volume (venue)
217,338
Avg Vol (3m, venue)
256,269.127

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-0.32%
1M
+0.23%
3M
+2.04%
6M
+66.67%
YTD
+116.63%
1Y
+71.27%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
45.50
SMA (50)
$31.68
SMA (200)
$23.65
Price vs SMA50
-2.16%
Price vs SMA200
+31.08%
ATR (14)
$1.48

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$11.7B
Net Income
$551M
Gross Margin
—
Operating Margin
5.4%
Net Margin
4.7%
Return on Equity
26.8%
Return on Assets
4.9%
Current Ratio
1.08
Debt / Equity
0.21
Revenue Growth (YoY)
+39.0%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $1.10 2026-08-07
Q1 2026 $2.07 2026-05-07
Q4 2025 (derived) -$1.19 2026-02-13
FY 2025 -$1.69 2026-02-13
Q3 2025 -$0.53 2025-11-06
Q2 2025 -$0.89 2025-08-07

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Hospital & Medical Service Plans peers

OSCR vs 10 industry peers (Hospital & Medical Service Plans), by market cap. Data as of close

P/E vs peers
17.37 / 24.01 med
-28% discount
P/S vs peers
0.82 / 0.40 med
+104% premium
Net margin vs peers
4.7% / 1.1% med
above median
1–10 of 10
UNHUnitedHealth Group$359.4B25.450.803.1%-1.54%
ELVElevance Health$89.4B17.390.442.5%-1.47%
CICigna$78.0B13.090.282.1%-1.03%
HUMHumana$49.3B43.590.360.8%-0.97%
CNCCentene Corporation$32.9B22.560.180.8%-2.80%
MOHMolina Healthcare, Inc.$10.9B—0.25-0.1%+1.88%
OSCROscar Health, Inc.$9.6B17.370.824.7%+2.11%
CLOVClover Health Investments, Corp. /De$2.3B—0.93-3.5%-3.25%
ALHCAlignment Healthcare, Inc.$1.5B50.480.300.6%-4.32%
TRUPTrupanion, Inc.$1.4B69.490.891.3%+1.99%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.